Med is a flagship medical journal published monthly by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Cancer Cell, and Cell Reports Medicine. Our mission is to advance clinical research and practice by providing a communication forum for the publication of clinical trial results, innovative observations from longitudinal cohorts, and pioneering discoveries about disease mechanisms. The journal also encourages thought-leadership discussions among biomedical researchers, physicians, and other health scientists and stakeholders. Our goal is to improve health worldwide sustainably and ethically.
Med publishes rigorously vetted original research and cutting-edge review and perspective articles on critical health issues globally and regionally. Our research section covers clinical case reports, first-in-human studies, large-scale clinical trials, population-based studies, as well as translational research work with the potential to change the course of medical research and improve clinical practice.
We are interested in research with immediate impact on clinical practice and health policy. These can be pre-defined outcomes from clinical trials, epidemiology studies from established cohorts, meta-analyses of clinical observations and trials, as well as translational research papers reporting substantial knowledge breakthroughs in disease mechanisms or technological advances with clear clinical impact.
Med (Med)
is :
International, Peer-Reviewed, Open Access, Refereed,
Cancer, Cardiovascular, metabolic diseases, Digital health, Healthy aging, Cancer Cell
,
Online
or
Print,
Monthly
Journal
UGC Approved, ISSN Approved: P-ISSN - 2666-6359, E-ISSN - 2666-6340, Established in - 2020, Impact Factor
Not Provide Crossref DOI
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE
Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Services for Journal Owners:
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
Indexing and Contact Detail:
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Limitations of Responsibility:
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Resolution of Disputes:
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.
True scholar network
